Are you getting the best antibody leads from your screening process?
Traditional methods, such as ELISA, report many false positives and negatives because
they cannot distinguish between expression level and affinity. These result in bottlenecks
in subsequent labor-intensive steps or the loss of important leads.
Benefits of BIND® for Antibody Lead Selection for Antibody Lead Selection
Smarter
AFFINITY RANKING of Antibodies in a 96-, 384- or 1536-well microplate biosensor
- Rank thousands of Fab or IgG samples in crude media for both concentration and target binding
- Obtain antibody concentration and affinity in a single experiment
- Reduce false positives and false negatives
- Characterize antibody binding to both soluble and cell surface expressed targets
- No need for a specialized operator
- Fully compatible with lab automation & robotics
UNIVERSAL
ASSAY SYSTEM can be applied across the antibody discovery process
- Obtain primary antibody screen and binding characterization from a single platform
- Assay cells, proteins, peptides, complex systems
- Address assay development, antibody lead selection and epitope analysis with a suite of applications
- Visualize each binding step to simplify assay development
A label-free assay system that is compatible with
CRUDE/COMPLEX SAMPLES
- Use test samples directly without purification or concentration
- Eliminate need for secondary reagents
- Avoid concerns associated with labeling of target proteins
